JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) - USD ($)		1 Months Ended			12 Months Ended		50 Months Ended	53 Months Ended
	Aug. 03, 2012	Aug. 25, 2016	Jun. 01, 2016	Mar. 31, 2016	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016	Dec. 31, 2016
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	$ 6,000,000				$ 6,000,000			$ 6,000,000
Joint Venture Investments In Voting Common Ownership Units (in shares)	600,000
Joint Venture Investments In Non Voting Preferred Ownership Units	5,000,000
Development Activities Monthly Fee	$ 63,000
Joint Venture, Operating Expenses, Inter Company Transactions					1,081,000			8,462,000
Joint Venture, Operating Expenses Allocated To Company					946,000			6,850,000
Percentage Of Non Royalty Income	5.00%
Conversion of Stock, Shares Converted				1,500,000
Conversion of Stock, Shares Issued				120,000
Joint Venture Method Investment Ownership Percentage	60.00%
Proceeds from Issuance of Preferred Stock and Preference Stock					946,000	$ 0
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		33,088
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 10.70
Management Fees			$ 80,000
Professional Fees			$ 10,000
Operating Expenses Net Of Elimination Of Intercompany Transactions					137,000
Preferred Stock And Warrant Purchase Agreement [Member]
Related Party Transaction [Line Items]
Stock And Warrant Purchase Agreement Number Of Shares To Be Issued		15,975
Series B1 Preferred Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity		$ 946,000
Joint Venture Method Investment Ownership Percentage		59.30%
Preferred Stock,Converted Basis Post-Closing Common Stock ,Percentage		7.80%
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs		$ 1,012,000
Proceeds from Issuance of Preferred Stock and Preference Stock		946,000			946,000
Payments of Stock Issuance Costs		$ 66,000
Stock Issued During Period, Shares, New Issues		94,537
Professional Fees					60,000
Management Fee Expense					300,000
Series B1 Preferred Stock [Member] | Preferred Stock And Warrant Purchase Agreement [Member]
Related Party Transaction [Line Items]
Stock And Warrant Purchase Agreement Number Of Shares To Be Issued		45,640
Series B2 Preferred Stock [Member] | Preferred Stock And Warrant Purchase Agreement [Member]
Related Party Transaction [Line Items]
Stock And Warrant Purchase Agreement Number Of Shares To Be Issued		1,200,000
Series B Preferred Stock [Member] | Preferred Stock And Warrant Purchase Agreement [Member]
Related Party Transaction [Line Items]
Preferred Stock, Dividend Rate, Percentage		5.00%
Revolving Credit Facility [Member]
Related Party Transaction [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity					1,600,000			1,600,000
Long-term Line of Credit					1,594,000			1,594,000
Common Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity					$ 0			$ 0
Preferred Stock [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent					100.00%			100.00%
Noncontrolling Interest [Member]
Related Party Transaction [Line Items]
Noncash or Part Noncash Acquisition, Other Liabilities Assumed							$ 667,000
Maximum [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage				64.00%
Minimum [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage				60.00%
Exclusive License Agreement [Member]
Related Party Transaction [Line Items]
Percentage Of Royalty Payment	3.00%
Annual Maintenance Payments	$ 25,000
Exclusive License Agreement [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Milestone Payments	500,000
Royalty Expense	1,000,000
Exclusive License Agreement [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Milestone Payments	50,000
Royalty Expense	$ 500,000
Lipimetix [Member]
Related Party Transaction [Line Items]
Joint Venture Investments Common Ownership Units, Co-venture (in shares)	400,000
Ownership Percentage Co-venture	40.00%				36.00%
Noncash or Part Noncash Acquisition, Other Liabilities Assumed					$ 667,000
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed), Total	$ 378,000				$ 378,000
Voting Common Ownership Units [Member]
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	1,000,000
Non Voting Preferred Ownership Units [Member]
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	$ 5,000,000